PBLS Parabilis Medicines, Inc.
Price Chart
Executive Summary
Alexis Borisy filed a Form 3 initial statement of beneficial ownership with Parabilis Medicines, Inc., disclosing 105,414 shares of common stock and an undisclosed amount of Series F Preferred Stock convertible into common stock on a 1-to-0.6498 basis. This is a routine insider filing required upon becoming an officer, director, or 10% holder and contains no trading activity or material new information.
Actionable Insight
This is a routine Form 3 filing with no trading activity or material corporate event. No immediate action required. Monitor future Form 4 filings for any insider transactions that may signal conviction or concern.
Key Facts
- Alexis Borisy filed a Form 3 initial statement of beneficial ownership with Parabilis Medicines, Inc. on June 9, 2026.
- Borisy reported beneficial ownership of 105,414 shares of common stock.
- Borisy also reported ownership of Series F Preferred Stock (amount not specified), convertible into common stock on a 1-to-0.6498 basis and automatically converting prior to the issuer's IPO.
- The filing includes a limited power of attorney authorizing Teresa Jurgensen and Thomas Kotarakos to execute Section 16 and Schedule 13D/13G filings on Borisy's behalf.
- No transactions were reported; this is an initial ownership statement only.
Financial Impact
No financial impact; routine initial ownership disclosure.
Risk Factors
- No material risks identified from this filing.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-264556 |
| Document: 0001193125-26-264556-index-headers.html | 0001193125-26-264556 |
| Document: 0001193125-26-264556-index.html | 0001193125-26-264556 |
| Document: 0001193125-26-264556.txt | 0001193125-26-264556 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
3d ago
|
8-K
| $30.30 awaiting T+20 | awaiting T+20 | — | $27.26 (−10.03%) |
|
Jun 10, 2026
4d ago
|
424B4
| $32.16 awaiting T+20 | awaiting T+20 | — | $27.26 (−15.24%) |
|
Jun 10, 2026
5d ago
|
EFFECT
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
3
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
|
Jun 10, 2026
5d ago
|
Press Release
| $33.35 awaiting T+20 | awaiting T+20 | — | $27.26 (−18.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access